Discover Different People Innovation Caring Science Cardiovascular Health Award Winning Integrity Passionate LEADING A NEW PARADIGM IN CARDIOVASCULAR DISEASE MANAGEMENT Amarin Corporation is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve patient health. Our lead commercial product, VASCEPA® (icosapent ethyl), creates a new paradigm in cardiovascular disease management and is positioned to address cardiovascular risk for millions of patients globally. The efficacy and safety profile of VASCEPA, as demonstrated in the landmark REDUCE-IT® cardiovascular outcomes study, has been heralded as one of the most significant breakthroughs in preventative cardiovascular care since statin therapy was introduced nearly three decades ago. VASCEPA is supported by over 100 scientific publications and presentations and recommended for use in appropriate at-risk patients by leading medical societies from around the world, including the United States and Europe. The REDUCE-IT results stand in stark contrast to earlier generation drugs, the clinical studies of which failed to show reduction of persistent cardiovascular risk in their studied populations. LEARN MORE >> VASCEPA® (icosapent ethyl) CARDIOVASCULAR HEALTH INVESTORS RECENT PRESS RELEASES Jun 2, 2021 Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021 May 18, 2021 Amarin to Present at Two Investor Conferences in June 2021 Sign up for Email Alerts SIGN UP TODAY For Amarin’s most recent Investor Presentation CLICK HERE © 2021 Amarin Corporation All rights reserved. Disclaimer Privacy Policy Contact Us Amarin is headquartered in Dublin, Ireland. In the U.S., the company's office is in Bridgewater, New Jersey. Amarin is listed in the U.S. on NASDAQ (symbol: "AMRN"). AMARIN, VASCEPA, VAZKEPA and REDUCE-IT are trademarks of Amarin Pharmaceuticals Ireland Limited. VAZKEPA is a registered trademark in Europe and other countries and regions and is pending registration in the United States.